Transmutex
9 known investors
Transmutex develops accelerator-powered technology that converts nuclear waste into clean energy and produces medical radioisotopes. The company serves energy providers, waste management operators, and healthcare providers across the nuclear energy, waste management, and medical sectors.
Investors · 9
4see VenturesChêne-Bougeries · $432K – $1.1Mvia Daniel Bertholet · inferred
AlleyCorpNew York · $1M – $5M
At One VenturesMenlo Park · $100K – $5M
Hardware ClubNew York
HCVCParis · $100K – $1M
Steel AtlasNew York
Union Square Ventures (USV)New York · $1M – $20M
Verve VenturesZug · $1.1M – $2.2M
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
In the news
- Transmutex receives CHF 20 million for its breakthrough nuclear energy technology | S-GEs-ge.com · 2025
- Transmutex SA, a Geneva-based company, raises over CHF 20 million in an extension of its Series A to further develop and commercialize its subcritical nuclear energy systemprnewswire.com · 2024
- The Startup Using Thorium As A New Approach To Nuclear Energy | The New Moneythenew.money · 2024
- Transmutex raises over CHF 20M in extension of Series A fundinglenzstaehelin.com